Drug
C16g2
C16g2: highest development phase Phase 2, developed by Armata Pharmaceuticals. 4 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Armata Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| C16G2 Gel NCT02594254 | Phase 2 | Dental Caries |
| C16G2 NCT03196219 | Phase 2 | Dental Caries |
| C16G2 NCT02509845 | Phase 2 | Dental Caries |
| C16G2 NCT02254993 | Phase 2 | Dental Caries |
Latest
No recent events.
Follow C16g2 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.